ID: ALA5266955

Max Phase: Preclinical

Molecular Formula: C21H21N5O2S

Molecular Weight: 407.50

Associated Items:

Representations

Canonical SMILES:  CCOc1ccccc1N/N=C1/C(=O)N(C2=NC(c3ccccc3)CS2)N=C1C

Standard InChI:  InChI=1S/C21H21N5O2S/c1-3-28-18-12-8-7-11-16(18)23-24-19-14(2)25-26(20(19)27)21-22-17(13-29-21)15-9-5-4-6-10-15/h4-12,17,23H,3,13H2,1-2H3/b24-19+

Standard InChI Key:  AEJUFZZDEUKSGS-LYBHJNIJSA-N

Associated Targets(Human)

Apoptosis regulator BAX 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 407.50Molecular Weight (Monoisotopic): 407.1416AlogP: 3.92#Rotatable Bonds: 5
Polar Surface Area: 78.65Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.35CX Basic pKa: 1.94CX LogP: 5.27CX LogD: 4.26
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.76Np Likeness Score: -1.00

References

1. Pogmore JP, Uehling D, Andrews DW..  (2021)  Pharmacological Targeting of Executioner Proteins: Controlling Life and Death.,  64  (9.0): [PMID:33939407] [10.1021/acs.jmedchem.0c02200]

Source